Browse by Uncontrolled Keywords
Number of items: 5.
2017
Mamza, J;
Mehta, R;
Donnelly, R;
Idris, I;
(2017)
Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Annals of medicine, 48 (4).
pp. 224-34.
ISSN 0785-3890
DOI: https://doi.org/10.3109/07853890.2016.1157263
2016
Anyanwagu, U;
Mamza, J;
Mehta, R;
Donnelly, R;
Idris, I;
(2016)
Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.
Heart (British Cardiac Society), 102 (19).
pp. 1581-7.
ISSN 1355-6037
DOI: https://doi.org/10.1136/heartjnl-2015-309164
Mamza, J;
Mehta, R;
Donnelly, R;
Idris, I;
(2016)
Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database.
Diabetes technology & therapeutics, 18 (2).
pp. 85-92.
ISSN 1520-9156
DOI: https://doi.org/10.1089/dia.2015.0052
2013
Goring, S;
Hawkins, N;
Wygant, G;
Roudaut, M;
Townsend, R;
Wood, I;
Barnett, AH;
(2013)
Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: A systematic review and network meta-analysis.
Diabetes, obesity & metabolism, 16.
pp. 433-442.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.12239
Full text not available from this repository.
2011
Gross, JL;
Kramer, CK;
Leitão, CB;
Hawkins, N;
Viana, LV;
Schaan, BD;
Pinto, LC;
Rodrigues, TC;
Azevedo, MJ;
(2011)
Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: A network meta-analysis.
Annals of internal medicine, 154.
pp. 672-679.
ISSN 0003-4819
DOI: https://doi.org/10.7326/0003-4819-154-10-201105170-00007
Full text not available from this repository.